Morgan Stanley’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126M Sell
2,549,908
-678,388
-21% -$34.4M 0.01% 1375
2026
Q1
$172M Sell
3,228,296
-211,727
-6% -$12.4M 0.01% 1045
2025
Q4
$214M Buy
3,440,023
+432,620
+14% +$26.7M 0.01% 907
2025
Q3
$181M Buy
3,007,403
+78,770
+3% +$4.82M 0.01% 995
2025
Q2
$183M Buy
2,928,633
+149,410
+5% +$8.98M 0.01% 928
2025
Q1
$167M Sell
2,779,223
-72,951
-3% -$4.53M 0.01% 942
2024
Q4
$166M Sell
2,852,174
-81,840
-3% -$4.86M 0.01% 928
2024
Q3
$174M Sell
2,934,014
-208,567
-7% -$11.9M 0.01% 903
2024
Q2
$176M Sell
3,142,581
-104,006
-3% -$5.82M 0.01% 867
2024
Q1
$190M Sell
3,246,587
-53,080
-2% -$3M 0.02% 826
2023
Q4
$178M Sell
3,299,667
-45,915
-1% -$2.24M 0.02% 829
2023
Q3
$162M Sell
3,345,582
-647,645
-16% -$34.4M 0.02% 791
2023
Q2
$225M Buy
3,993,227
+34,699
+0.9% +$1.91M 0.02% 663
2023
Q1
$214M Buy
3,958,528
+42,657
+1% +$2.27M 0.02% 669
2022
Q4
$206M Buy
3,915,871
+245,906
+7% +$12.5M 0.02% 672
2022
Q3
$173M Sell
3,669,965
-755,151
-17% -$39.2M 0.02% 631
2022
Q2
$223M Buy
4,425,116
+367,486
+9% +$20M 0.03% 546
2022
Q1
$247M Sell
4,057,630
-756,520
-16% -$45.1M 0.03% 460
2021
Q4
$317M Buy
4,814,150
+567,283
+13% +$36.3M 0.04% 409
2021
Q3
$267M Buy
4,246,867
+198,799
+5% +$12.7M 0.04% 440
2021
Q2
$244M Sell
4,048,068
-1,019,088
-20% -$58.9M 0.03% 476
2021
Q1
$279M Sell
5,067,156
-1,076,862
-18% -$59.7M 0.04% 380
2020
Q4
$335M Buy
6,144,018
+570,876
+10% +$29.8M 0.05% 312
2020
Q3
$278M Sell
5,573,142
-4,162,242
-43% -$202M 0.05% 297
2020
Q2
$430M Buy
9,735,384
+591,960
+6% +$25.3M 0.1% 197
2020
Q1
$343M Buy
9,143,424
+1,143,192
+14% +$48.1M 0.09% 194
2019
Q4
$352M Buy
8,000,232
+1,593,318
+25% +$67M 0.08% 230
2019
Q3
$264M Sell
6,406,914
-52,110
-0.8% -$2.13M 0.07% 278
2019
Q2
$259M Buy
6,459,024
+700,266
+12% +$26.5M 0.07% 283
2019
Q1
$222M Buy
5,758,758
+1,028,592
+22% +$37.3M 0.06% 304
2018
Q4
$158M Sell
4,730,166
-671,112
-12% -$23.2M 0.05% 376
2018
Q3
$205M Buy
5,401,278
+1,353,636
+33% +$48.1M 0.05% 350
2018
Q2
$135M Buy
4,047,642
+386,928
+11% +$12.6M 0.04% 459
2018
Q1
$113M Sell
3,660,714
-763,998
-17% -$23.5M 0.03% 530
2017
Q4
$128M Buy
4,424,712
+103,200
+2% +$2.98M 0.04% 495
2017
Q3
$120M Buy
4,321,512
+1,419,036
+49% +$39.3M 0.04% 478
2017
Q2
$80.6M Buy
2,902,476
+452,304
+18% +$12M 0.02% 664
2017
Q1
$61.8M Sell
2,450,172
-814,674
-25% -$19.8M 0.02% 788
2016
Q4
$72.5M Buy
3,264,846
+362,496
+12% +$8.23M 0.02% 678
2016
Q3
$70.3M Buy
2,902,350
+902,202
+45% +$21.5M 0.02% 670
2016
Q2
$45.2M Sell
2,000,148
-237,606
-11% -$5.15M 0.02% 849
2016
Q1
$45.7M Buy
2,237,754
+866,172
+63% +$16.8M 0.02% 803
2015
Q4
$28M Buy
1,371,582
+634,458
+86% +$12.7M 0.01% 1164
2015
Q3
$13.7M Sell
737,124
-1,045,770
-59% -$21M 0.01% 1688
2015
Q2
$35.6M Buy
1,782,894
+934,608
+110% +$18.7M 0.01% 1069
2015
Q1
$17M Sell
848,286
-126,426
-13% -$2.47M 0.01% 1589
2014
Q4
$18.4M Buy
974,712
+100,956
+12% +$1.82M 0.01% 1541
2014
Q3
$14.5M Sell
873,756
-114,330
-12% -$1.95M 0.01% 1701
2014
Q2
$16.8M Sell
988,086
-45,942
-4% -$751K 0.01% 1572
2014
Q1
$17M Buy
1,034,028
+59,226
+6% +$950K 0.01% 1509
2013
Q4
$15.1M Buy
974,802
+74,280
+8% +$1.11M 0.01% 1582
2013
Q3
$12.7M Sell
900,522
-61,266
-6% -$842K 0.01% 1575
2013
Q2
$12.6M Buy
+961,788
New +$12.5M 0.01% 1518

Other funds holding IHI

Morgan Stanley's IHI Position: Q2 2026 in Review

Morgan Stanley reduced its iShares US Medical Devices ETF (IHI) stake by 21% in Q2 2026, selling an estimated $34.4M and leaving 2,549,908 shares worth $126M. The position accounts for 0.01% of the portfolio, ranked #1375.

Morgan Stanley first reported a position in IHI in Q2 2013 and has held it in 53 quarters since. The position peaked at $430M in Q2 2020. 500 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Morgan Stanley held 2,549,908 shares of iShares US Medical Devices ETF worth $126M as of Q2 2026.
  • Morgan Stanley sold 678,388 iShares US Medical Devices ETF shares in Q2 2026, an estimated $34.4M.
  • iShares US Medical Devices ETF made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1375 holding.
  • Morgan Stanley first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 53 quarters since.
  • Morgan Stanley's iShares US Medical Devices ETF position peaked at $430M in Q2 2020.
  • 500 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.